Prostate cancer is the most frequently diagnosed non-cutaneous cancer, and is the second leading cause of cancer death in American men. It has been observed that elevated blood estrogen in the presence of high testosterone is an important risk factor that contributes to the prostate carcinogenesis. Dietary factors potentially linked to prostate cancer are numerous; however, an understanding of the mechanism(s) by which certain nutrients would protect the prostate from the genetic damage that is associated with tumor development remains unclear. The objectives of this application are to define the molecular mechanisms that link sex hormonal (estrogens/testosterone) stimulation to chronic inflammation, generation of reactive oxygen species (ROS) and uncontrolled prostate cell proliferation, and to evaluate the effectiveness of dietary strategies that target these processes. The central hypothesis of this application is that elevated estrogen, in the presence of high testosterone, causes prolonged activation of a redox-sensitive transcription factor, NFkappaB, through an estrogen receptor-mediated process. Prolonged NFkappaB activation initiates and amplifies an inflammatory cascade within the prostate and results in sustained oxidative damage and signals for cell proliferation in the prostate. We further hypothesize that consumption of antioxidant-rich foods containing a combination of anti-estrogenic, anti-inflammatory and anti-proliferative components will be effective in reducing the prevalence of prostate cancer.
The Aims of this project are: 1) to identify the molecular mechanisms by which exposure to elevated estrogen/testosterone causes chronic inflammation in prostate tissues of Noble rats, 2) to characterize the links of chronic inflammation leading to oxidative stress and proliferation signals in the prostate during sex hormone-induced prostate carcinogenesis, and 3) to evaluate the ability of novel whole food-based dietary modifications to prevent sex hormone-induced prostate carcinogenesis in Noble rats. The successful completion of our study is expected to reveal novel relationships among divergent factors involved in prostate cancer and aid in identifying key molecular targets for dietary intervention for prostate cancer prevention. Our 'whole food' based approach to cancer prevention is highly relevant to the development of evidence based and broadly applicable public health recommendations that will significantly reduce the burden of prostate cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA107693-02
Application #
6915221
Study Section
Special Emphasis Panel (ZCA1-SRRB-D (J2))
Program Officer
Kim, Young Shin
Project Start
2004-07-01
Project End
2009-05-31
Budget Start
2005-07-07
Budget End
2006-05-31
Support Year
2
Fiscal Year
2005
Total Cost
$255,583
Indirect Cost
Name
Oregon State University
Department
Type
Other Domestic Higher Education
DUNS #
053599908
City
Corvallis
State
OR
Country
United States
Zip Code
97339
Hsu, Anna; Bruno, Richard S; Löhr, Christiane V et al. (2011) Dietary soy and tea mitigate chronic inflammation and prostate cancer via NF?B pathway in the Noble rat model. J Nutr Biochem 22:502-10
Hsu, Anna; Bray, Tammy M; Ho, Emily (2010) Anti-inflammatory activity of soy and tea in prostate cancer prevention. Exp Biol Med (Maywood) 235:659-67
Wong, Carmen P; Bray, Tammy M; Ho, Emily (2009) Induction of proinflammatory response in prostate cancer epithelial cells by activated macrophages. Cancer Lett 276:38-46
Dashwood, Roderick H; Ho, Emily (2008) Dietary agents as histone deacetylase inhibitors: sulforaphane and structurally related isothiocyanates. Nutr Rev 66 Suppl 1:S36-8
Clarke, John D; Dashwood, Roderick H; Ho, Emily (2008) Multi-targeted prevention of cancer by sulforaphane. Cancer Lett 269:291-304
Dashwood, Roderick H; Ho, Emily (2007) Dietary histone deacetylase inhibitors: from cells to mice to man. Semin Cancer Biol 17:363-9
Myzak, Melinda C; Tong, Philip; Dashwood, Wan-Mohaiza et al. (2007) Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects. Exp Biol Med (Maywood) 232:227-34
Colgate, Emily C; Miranda, Cristobal L; Stevens, Jan F et al. (2007) Xanthohumol, a prenylflavonoid derived from hops induces apoptosis and inhibits NF-kappaB activation in prostate epithelial cells. Cancer Lett 246:201-9
Myzak, Melinda C; Hardin, Karin; Wang, Rong et al. (2006) Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells. Carcinogenesis 27:811-9